| Literature DB >> 30197543 |
Srisuda Songthamwat1, Metha Songthamwat1.
Abstract
OBJECTIVE: The aim of this study was to report our clinical experience of applying a uterine flexion suture, which was modified from the B-Lynch uterine compression suture, for treating uterine atony during cesarean section.Entities:
Keywords: B-Lynch; cesarean section; uterine atony; uterine compression suture; uterine flexion suture
Year: 2018 PMID: 30197543 PMCID: PMC6113941 DOI: 10.2147/IJWH.S170460
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Figure 1Uterine flexion suture technique.
Notes: (1) The suture first begins at 1–2 cm below right inferior edge and 3–4 cm from the lateral border, (2) the suture is then passed to the upper incision margin 1–2 cm above and 3–4 cm from the left lateral border, (3) it is entered the posterior wall of uterus at the same level as the upper anterior entry point, (4) the suture is placed horizontally at the midline of the uterus witĥ1–2 cm depth, and (5 and 6) the needle is passed in the same fashion to the left side.
Characteristics of patients
| Characteristics | Number |
|---|---|
| Total number of patients (cases) | 57 |
| Age (years), mean ± SD (range) | 27.0±7.1 (15–44) |
| Gestational age, mean ± SD (range) | 37.5+1.9 (32–41) |
| Parity, n (%) | |
| Primipara | 34 (59.7) |
| Multipara | 23 (40.3) |
| Indication, n (%) | |
| Cephalopelvic disproportion | 27 (47.4) |
| Previous cesarean section | 11 (19.3) |
| Twin pregnancy | 6 (10.5) |
| Fetal distress | 5 (8.8) |
| Preeclampsia | 3 (5.3) |
| Others | 5 (8.8) |
| Risk factors of uterine atony, n (%) | |
| Obesity | 34 (59.7) |
| Induction or augmentation of labor | 14 (24.6) |
| Prolonged labor | 12 (21.1) |
| Multifetal pregnancy | 6 (10.5) |
| Received magnesium sulfate | 6 (10.5) |
| Others | 6 (10.5) |
| Uterotonic agents used, n (%) | |
| Oxytocin | 57 (100) |
| Methylergonovine maleate (Methergin®) | 47 (82.5) |
| Sulprostone (Nalador®) | 37 (64.9) |
Results of treatment
| Results | Cases |
|---|---|
| Uterine preservation, n (%) | 57 (100) |
| Estimated blood loss (mL), mean ± SD (range) | 468.4±274.5 (200–1,500) |
| Estimated blood loss >500 mL, n (%) | 14 (24.6) |
| Postpartum hemorrhage (>1,000 mL), n (%) | 5 (8.8) |
| Complication, n (%) | |
| Febrile morbidity | 5 (8.8) |
| Fertility after procedure, n (%) | |
| Tubal resection | 22 (38.6) |
| Contraception | 13 (22.8) |
| Pregnancy | 4 (7.0) |
| No pregnancy | 9 (15.8) |
| Loss to follow-up | 9 (15.8) |